FDA Inspection 1311832 — Austin Laboratory New Health

Austin Laboratory New Health — FEI 3008804132

The FDA completed an inspection of Austin Laboratory New Health on March 31, 2026 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 31, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Austin, TX (United States)